Totally epicardial cardiac resynchronization therapy system implantation in patients with heart failure undergoing CABG

Gościńska-Bis, Kinga; Bis, Jarosław; Krejca, Michał; Ulczok, Rafał; Szmagała, Przemysław; Bochenek, Andrzej; Kargul, Włodzimierz

doi:10.1016/j.ejheart.2008.03.007

Cited by 16 publications

(11 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Overall Jehn et al 50 Radke et al 24 Alahdab et al 18 Alahdab et al 18 Rostagno et al 13 Rostagno et al 45 Ingle et al 26 Jehn et al 36 Ingle et al 26 Deuschle et al 52 Rostagno et al 46 Bagur et al 48 Zugck et al 21 Pepera et al 32 Goode et al 18 Deuschle et al 52 Faggiano et al 47 Leszek et al 35 Rostagno et al 13 Goode et al 7 Zugck et al 21 Ingle et al 26 Ingle et al 26 Rostagno et al 45 Tay et al 49 Jankowska et al 29 Bagur et al 48 Ates et al 30 Rostagno et al 46 Gary et al 25 Jehn et al 36 Karavidaset al 28 Souza et al 53 Jehn et al 50 Bosnak Güçlü et al 27 Alahdab et al 18 Forman et al 20 Zaidi et al Goscinska-Bis et al 37 Alahdab et al 18 Forman et al 20 Keast et al 31 Vrtovec et al 51 Rostagno et al 45 Souza et al 53 Tay et al 49 Jaski et al 34 Zugck et al …”

Section: Discussionmentioning

confidence: 99%

Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review

Yap

Lim

Gao

et al. 2015

Clinical Cardiology

View full text Add to dashboard Cite

Background: Functional status assessment is the cornerstone of heart failure management and trials. The New York Heart Association (NYHA) classification and 6-minute walk distance (6MWD) are commonly used tools; however, the correlation between them is not well understood. Hypothesis: We hypothesised that the relationship between the NYHA classification and 6MWD might vary across studies. Methods: A systematic literature search was performed to identify all studies reporting both NYHA class and 6MWD. Two reviewers independently assessed study eligibility and extracted data. Thirty-seven studies involving 5678 patients were included. Results: There was significant heterogeneity across studies in 6MWD within all NYHA classes: I (n = 16, Q = 934.2; P < 0.001), II (n = 25, Q = 1658.3; P < 0.001), III (n = 30, Q = 1020.1; P < 0.001), and IV (n = 6, Q = 335.5; P < 0.001). There was no significant difference in average 6MWD between NYHA I and II (420 m vs 393 m; P = 0.416). There was a significant difference in average 6MWD between NYHA II and III (393 m vs 321 m; P = 0.014) and III and IV (321 m vs 224 m; P = 0

show abstract

Section: Discussionmentioning

confidence: 99%

Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review

Yap

Lim

Gao

et al. 2015

Clinical Cardiology

View full text Add to dashboard Cite

show abstract

“…In contrast, a limited number of other studies have shown a beneficial effect of CRT and epicardial leads placed in association to cardiac surgery. In a small study on CRT with epicardial leads during CABG in patients with HF [12], a better estimated QoL was seen in patients with active CRT. Similarly, CRT improved QoL and LV systolic function after CABG in HF patients with ventricular dyssynchrony [13].…”

Section: Discussionmentioning

confidence: 99%

“…We did not detect any negative influence on QoL from CRT. Other authors have reported positive findings [12,13] and CRT may have a role in the treatment in selected patients with HF and ventricular dyssynchrony undergoing CABG and/or AVR surgery.…”

Section: Discussionmentioning

confidence: 99%

“…The surgical technique results in more successful left lead positioning, same level of clinical improvement, lower left ventricular (LV) related complication rates and lower chronic threshold-capture compared to transvenous lead placement via the coronary sinus [10,11]. Perioperative CRT-implantation in CABG patients seems to carry a positive effect on functional status and QoL in addition to the outcome of surgery [12,13]. The information available on concomitant CRT-implantation in association with cardiac surgery is, however, limited.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Effect of Concomitant Cardiac Resynchronization Therapy on Quality of Life in Patients with Heart Failure Undergoing Cardiac Surgery

Thorén¹,

Kesek²,

Jidéus³

2014

TOCMJ

View full text Add to dashboard Cite

Objectives:To evaluate the effect of concomitant cardiac resynchronization therapy (CRT) on health related quality of life (QoL) in patients with heart failure (HF) and ventricular dyssynchrony undergoing cardiac surgery.Methods:Twenty-eight patients received permanent epicardial CRT in connection to coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR) (CRT group). Thirty-seven HF patients without concomitant CRT served as a comparison group (non-CRT group). SF-36 was used to assess QoL in the two groups and was also compared with the general Swedish population.Results:The median follow-up time was 28 months after surgery (range 8 to 44 months). No difference in QoL could be shown between the CRT group and the comparison group. Several subscales of QoL in the CRT group were in range with the general Swedish population.Conclusion:Concomitant CRT for patients with HF and ventricular dyssynchrony undergoing CABG and/or AVR did not result in a higher estimated QoL compared to HF patients without CRT.

show abstract

“…Such patients could have a CRT device implanted at the time of CABG surgery using epicardial pacing leads. A previous pilot study of the combined technique in 23 patients showed encouraging results 22…”

Section: Coronary Artery Bypass Grafting With Cardiac Resynchronimentioning

confidence: 90%

Clinical trials update from the European Society of Cardiology Heart Failure Meeting 2010: TRIDENT 1, BENEFICIAL, CUPID, RFA‐HF, MUSIC, DUEL, handheld BNP, phrenic nerve stimulation, CHAMPION and CABG with CRT study

Cleland

Coletta

Clark

2010

European J of Heart Fail

View full text Add to dashboard Cite

This article provides information and a commentary on key trials relevant to the pathophysiology, prevention and treatment of heart failure (HF) presented at the annual meeting of the Heart Failure Association of the European Society of Cardiology held in Berlin. Unpublished reports should be considered as preliminary, since analyses may change in the final publication. Tonapofylline failed to show efficacy and was associated with an approximately 1% increased risk of seizures in patients with acute decompensated heart failure (ADHF) and renal dysfunction in TRIDENT. Results from BENEFICIAL do not support the use of alagebrium, an advanced glycation end‐product breaker, in clinically stable patients with relatively mild HF symptoms. CUPID showed encouraging preliminary results for augmentation of SERCA2a enzyme activity by gene transfection in patients with severe HF. The RFA‐HF study did not provide convincing evidence for the use of radiofrequency ablation for atrial fibrillation but was underpowered. A wearable, multi‐sensor patch showed potential for detecting impending HF decompensation in MUSIC. A comparison of low‐intensity oral diuretic therapy in patients hospitalized with ADHF suggested that torasemide was superior to furosemide in DUEL. The use of point‐of‐care B‐type natriuretic peptide and echocardiography failed to improve the rate of correct HF diagnosis in primary care. Phrenic nerve stimulation improved symptoms of sleep apnoea in a small study of patients with HF and central sleep apnoea. The use of a novel implantable pulmonary artery pressure monitoring system to guide patient management improved outcomes in the CHAMPION study. A study to evaluate a combined coronary artery bypass grafting (CABG) and epicardial cardiac resynchronization therapy implantation procedure reduced mortality compared with CABG alone.

show abstract

Totally epicardial cardiac resynchronization therapy system implantation in patients with heart failure undergoing CABG

Cited by 16 publications

References 28 publications

Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review

Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review

The Effect of Concomitant Cardiac Resynchronization Therapy on Quality of Life in Patients with Heart Failure Undergoing Cardiac Surgery

Clinical trials update from the European Society of Cardiology Heart Failure Meeting 2010: TRIDENT 1, BENEFICIAL, CUPID, RFA‐HF, MUSIC, DUEL, handheld BNP, phrenic nerve stimulation, CHAMPION and CABG with CRT study

Contact Info

Product

Resources

About